USA Trends and Developments Contributed by: Nadia de la Houssaye, Andy Lee, Jason Loring and Graham Ryan, Jones Walker LLP
evolution from experimental applications to essential operational tools. Major technology corporations are driving signifi - cant innovation in healthcare AI through substantial research and development investments. Companies such as Google Health, Microsoft Healthcare, Ama - zon Web Services and IBM Watson Health continue to develop foundational AI platforms and tools. Large health systems and academic medical centres lead healthcare AI adoption through dedicated innovation centres, research partnerships and pilot programmes, often serving as testing grounds for emerging AI tech - nologies. Pharmaceutical companies increasingly integrate AI throughout drug development pipelines, from tar - get identification and molecular design to clinical trial optimisation and regulatory submissions. These investments aim to reduce development costs and timelines while improving success rates for new thera - peutic approvals. Large healthcare technology companies increasingly acquire specialised AI start-ups to integrate innovative capabilities into comprehensive healthcare platforms. These acquisitions accelerate technology deployment while providing start-ups with the resources neces - sary for large-scale implementation and regulatory compliance. Emerging Technologies and Integration Challenges The rapid advancement of generative AI technologies has introduced new regulatory and practical challeng - es for healthcare organisations. As of late 2023, the FDA had not approved any devices relying on purely generative AI architectures, creating uncertainty about the regulatory pathways for these increasingly sophis - ticated technologies. Generative AI’s ability to create synthetic content, including medical images and clini - cal text, requires new approaches to validation and oversight that traditional medical device frameworks may not adequately address. The distinction between clinical decision support tools and medical devices remains an ongoing area of regu - latory clarification. Software that provides information to healthcare providers for clinical decision-making
may or may not constitute a medical device depend - ing on the specific functionality and level of interpreta - tion provided. Healthcare AI systems must provide sufficient trans - parency to enable healthcare providers to understand system recommendations and limitations. The FDA emphasises the importance of explainable AI that allows clinicians to understand the reasoning behind algorithmic recommendations. AI systems must pro - vide understandable explanations for their recom - mendations, which healthcare providers in turn use to communicate with patients. The integration of AI with emerging technologies such as robotics, virtual reality and internet of medical things (IoMT) devices creates additional complexity for healthcare organisations attempting to navigate regulatory requirements and clinical implementation challenges. These convergent technologies offer significant potential benefits but also introduce new risks related to cybersecurity, data privacy and clinical safety that existing regulatory frameworks struggle to address comprehensively. AI-enabled remote monitoring systems utilise wear - able devices, IoMT sensors and mobile health appli - cations to continuously track patient vital signs, medi - cation adherence and disease progression. These technologies enable early intervention for deteriorat - ing conditions and support chronic disease manage - ment outside traditional healthcare settings, but face unique regulatory challenges related to device perfor - mance, user training and clinical oversight. Cybersecurity and Infrastructure Considerations Healthcare data remains a prime target for cybersecu - rity threats, with data breaches involving 500 or more healthcare records reaching near-record numbers in 2024, continuing an alarming upward trend. Health - care data remains a prime target for hackers due to its high value on black markets and the critical nature of healthcare operations, which makes organisations more likely to pay ransoms. The integration of AI systems, which often require access to vast amounts of patient data, further com - plicates the security landscape and creates new vul -
146 CHAMBERS.COM
Powered by FlippingBook